{"pmid":32398875,"title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.","text":["Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.","Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19) severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells from patients with varying severity of COVID-19 and from healthy people by using single-cell RNA sequencing. Proinflammatory monocyte-derived macrophages were abundant in the bronchoalveolar lavage fluid from patients with severe COVID-9. Moderate cases were characterized by the presence of highly clonally expanded CD8(+) T cells. This atlas of the bronchoalveolar immune microenvironment suggests potential mechanisms underlying pathogenesis and recovery in COVID-19.","Nat Med","Liao, Mingfeng","Liu, Yang","Yuan, Jing","Wen, Yanling","Xu, Gang","Zhao, Juanjuan","Cheng, Lin","Li, Jinxiu","Wang, Xin","Wang, Fuxiang","Liu, Lei","Amit, Ido","Zhang, Shuye","Zhang, Zheng","32398875"],"abstract":["Respiratory immune characteristics associated with Coronavirus Disease 2019 (COVID-19) severity are currently unclear. We characterized bronchoalveolar lavage fluid immune cells from patients with varying severity of COVID-19 and from healthy people by using single-cell RNA sequencing. Proinflammatory monocyte-derived macrophages were abundant in the bronchoalveolar lavage fluid from patients with severe COVID-9. Moderate cases were characterized by the presence of highly clonally expanded CD8(+) T cells. This atlas of the bronchoalveolar immune microenvironment suggests potential mechanisms underlying pathogenesis and recovery in COVID-19."],"journal":"Nat Med","authors":["Liao, Mingfeng","Liu, Yang","Yuan, Jing","Wen, Yanling","Xu, Gang","Zhao, Juanjuan","Cheng, Lin","Li, Jinxiu","Wang, Xin","Wang, Fuxiang","Liu, Lei","Amit, Ido","Zhang, Shuye","Zhang, Zheng"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32398875","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1038/s41591-020-0901-9","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666714494788698112,"score":9.490897,"similar":[{"pmid":32407669,"pmcid":"PMC7196896","title":"Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.","text":["Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.","The outbreaks of 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 infection have posed a severe threat to global public health. It is unclear how the human immune system responds to this infection. Here, we used metatranscriptomic sequencing to profile immune signatures in the bronchoalveolar lavage fluid of eight COVID-19 cases. The expression of proinflammatory genes, especially chemokines, was markedly elevated in COVID-19 cases compared to community-acquired pneumonia patients and healthy controls, suggesting that SARS-CoV-2 infection causes hypercytokinemia. Compared to SARS-CoV, which is thought to induce inadequate interferon (IFN) responses, SARS-CoV-2 robustly triggered expression of numerous IFN-stimulated genes (ISGs). These ISGs exhibit immunopathogenic potential, with overrepresentation of genes involved in inflammation. The transcriptome data was also used to estimate immune cell populations, revealing increases in activated dendritic cells and neutrophils. Collectively, these host responses to SARS-CoV-2 infection could further our understanding of disease pathogenesis and point toward antiviral strategies.","Cell Host Microbe","Zhou, Zhuo","Ren, Lili","Zhang, Li","Zhong, Jiaxin","Xiao, Yan","Jia, Zhilong","Guo, Li","Yang, Jing","Wang, Chun","Jiang, Shuai","Yang, Donghong","Zhang, Guoliang","Li, Hongru","Chen, Fuhui","Xu, Yu","Chen, Mingwei","Gao, Zhancheng","Yang, Jian","Dong, Jie","Liu, Bo","Zhang, Xiannian","Wang, Weidong","He, Kunlun","Jin, Qi","Li, Mingkun","Wang, Jianwei","32407669"],"abstract":["The outbreaks of 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 infection have posed a severe threat to global public health. It is unclear how the human immune system responds to this infection. Here, we used metatranscriptomic sequencing to profile immune signatures in the bronchoalveolar lavage fluid of eight COVID-19 cases. The expression of proinflammatory genes, especially chemokines, was markedly elevated in COVID-19 cases compared to community-acquired pneumonia patients and healthy controls, suggesting that SARS-CoV-2 infection causes hypercytokinemia. Compared to SARS-CoV, which is thought to induce inadequate interferon (IFN) responses, SARS-CoV-2 robustly triggered expression of numerous IFN-stimulated genes (ISGs). These ISGs exhibit immunopathogenic potential, with overrepresentation of genes involved in inflammation. The transcriptome data was also used to estimate immune cell populations, revealing increases in activated dendritic cells and neutrophils. Collectively, these host responses to SARS-CoV-2 infection could further our understanding of disease pathogenesis and point toward antiviral strategies."],"journal":"Cell Host Microbe","authors":["Zhou, Zhuo","Ren, Lili","Zhang, Li","Zhong, Jiaxin","Xiao, Yan","Jia, Zhilong","Guo, Li","Yang, Jing","Wang, Chun","Jiang, Shuai","Yang, Donghong","Zhang, Guoliang","Li, Hongru","Chen, Fuhui","Xu, Yu","Chen, Mingwei","Gao, Zhancheng","Yang, Jian","Dong, Jie","Liu, Bo","Zhang, Xiannian","Wang, Weidong","He, Kunlun","Jin, Qi","Li, Mingkun","Wang, Jianwei"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407669","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.chom.2020.04.017","keywords":["bronchoalveolar lavage fluid","covid-19","chemokines","coronavirus","hypercytokinemia","innate immune response","interferon response","interferon-stimulated genes","metatranscriptomic sequencing","sars-cov-2"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666950579744669696,"score":270.86227},{"pmid":32228226,"pmcid":"PMC7170362","title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.","text":["Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.","Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response.","Emerg Microbes Infect","Xiong, Yong","Liu, Yuan","Cao, Liu","Wang, Dehe","Guo, Ming","Jiang, Ao","Guo, Dong","Hu, Wenjia","Yang, Jiayi","Tang, Zhidong","Wu, Honglong","Lin, Yongquan","Zhang, Meiyuan","Zhang, Qi","Shi, Mang","Liu, Yingle","Zhou, Yu","Lan, Ke","Chen, Yu","32228226"],"abstract":["Circulating in China and 158 other countries and areas, the ongoing COVID-19 outbreak has caused devastating mortality and posed a great threat to public health. However, efforts to identify effectively supportive therapeutic drugs and treatments has been hampered by our limited understanding of host immune response for this fatal disease. To characterize the transcriptional signatures of host inflammatory response to SARS-CoV-2 (HCoV-19) infection, we carried out transcriptome sequencing of the RNAs isolated from the bronchoalveolar lavage fluid (BALF) and peripheral blood mononuclear cells (PBMC) specimens of COVID-19 patients. Our results reveal distinct host inflammatory cytokine profiles to SARS-CoV-2 infection in patients, and highlight the association between COVID-19 pathogenesis and excessive cytokine release such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. Furthermore, SARS-CoV-2 induced activation of apoptosis and P53 signalling pathway in lymphocytes may be the cause of patients' lymphopenia. The transcriptome dataset of COVID-19 patients would be a valuable resource for clinical guidance on anti-inflammatory medication and understanding the molecular mechansims of host response."],"journal":"Emerg Microbes Infect","authors":["Xiong, Yong","Liu, Yuan","Cao, Liu","Wang, Dehe","Guo, Ming","Jiang, Ao","Guo, Dong","Hu, Wenjia","Yang, Jiayi","Tang, Zhidong","Wu, Honglong","Lin, Yongquan","Zhang, Meiyuan","Zhang, Qi","Shi, Mang","Liu, Yingle","Zhou, Yu","Lan, Ke","Chen, Yu"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32228226","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1080/22221751.2020.1747363","keywords":["covid-19","cytokine","inflammation","lymphopenia","transcriptome profiling"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138492195831810,"score":260.89368},{"pmid":32377375,"pmcid":"PMC7197635","title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.","text":["Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.","COVID-19, caused by SARS-CoV-2, has recently affected over 1,200,000 people and killed more than 60,000. The key immune cell subsets change and their states during the course of COVID-19 remain unclear. We sought to comprehensively characterize the transcriptional changes in peripheral blood mononuclear cells during the recovery stage of COVID-19 by single-cell RNA sequencing technique. It was found that T cells decreased remarkably, whereas monocytes increased in patients in the early recovery stage (ERS) of COVID-19. There was an increased ratio of classical CD14(++) monocytes with high inflammatory gene expression as well as a greater abundance of CD14(++)IL1beta(+) monocytes in the ERS. CD4(+) T cells and CD8(+) T cells decreased significantly and expressed high levels of inflammatory genes in the ERS. Among the B cells, the plasma cells increased remarkably, whereas the naive B cells decreased. Several novel B cell-receptor (BCR) changes were identified, such as IGHV3-23 and IGHV3-7, and isotypes (IGHV3-15, IGHV3-30, and IGKV3-11) previously used for virus vaccine development were confirmed. The strongest pairing frequencies, IGHV3-23-IGHJ4, indicated a monoclonal state associated with SARS-CoV-2 specificity, which had not been reported yet. Furthermore, integrated analysis predicted that IL-1beta and M-CSF may be novel candidate target genes for inflammatory storm and that TNFSF13, IL-18, IL-2, and IL-4 may be beneficial for the recovery of COVID-19 patients. Our study provides the first evidence of an inflammatory immune signature in the ERS, suggesting COVID-19 patients are still vulnerable after hospital discharge. Identification of novel BCR signaling may lead to the development of vaccines and antibodies for the treatment of COVID-19.","Cell Discov","Wen, Wen","Su, Wenru","Tang, Hao","Le, Wenqing","Zhang, Xiaopeng","Zheng, Yingfeng","Liu, Xiuxing","Xie, Lihui","Li, Jianmin","Ye, Jinguo","Dong, Liwei","Cui, Xiuliang","Miao, Yushan","Wang, Depeng","Dong, Jiantao","Xiao, Chuanle","Chen, Wei","Wang, Hongyang","32377375"],"abstract":["COVID-19, caused by SARS-CoV-2, has recently affected over 1,200,000 people and killed more than 60,000. The key immune cell subsets change and their states during the course of COVID-19 remain unclear. We sought to comprehensively characterize the transcriptional changes in peripheral blood mononuclear cells during the recovery stage of COVID-19 by single-cell RNA sequencing technique. It was found that T cells decreased remarkably, whereas monocytes increased in patients in the early recovery stage (ERS) of COVID-19. There was an increased ratio of classical CD14(++) monocytes with high inflammatory gene expression as well as a greater abundance of CD14(++)IL1beta(+) monocytes in the ERS. CD4(+) T cells and CD8(+) T cells decreased significantly and expressed high levels of inflammatory genes in the ERS. Among the B cells, the plasma cells increased remarkably, whereas the naive B cells decreased. Several novel B cell-receptor (BCR) changes were identified, such as IGHV3-23 and IGHV3-7, and isotypes (IGHV3-15, IGHV3-30, and IGKV3-11) previously used for virus vaccine development were confirmed. The strongest pairing frequencies, IGHV3-23-IGHJ4, indicated a monoclonal state associated with SARS-CoV-2 specificity, which had not been reported yet. Furthermore, integrated analysis predicted that IL-1beta and M-CSF may be novel candidate target genes for inflammatory storm and that TNFSF13, IL-18, IL-2, and IL-4 may be beneficial for the recovery of COVID-19 patients. Our study provides the first evidence of an inflammatory immune signature in the ERS, suggesting COVID-19 patients are still vulnerable after hospital discharge. Identification of novel BCR signaling may lead to the development of vaccines and antibodies for the treatment of COVID-19."],"journal":"Cell Discov","authors":["Wen, Wen","Su, Wenru","Tang, Hao","Le, Wenqing","Zhang, Xiaopeng","Zheng, Yingfeng","Liu, Xiuxing","Xie, Lihui","Li, Jianmin","Ye, Jinguo","Dong, Liwei","Cui, Xiuliang","Miao, Yushan","Wang, Depeng","Dong, Jiantao","Xiao, Chuanle","Chen, Wei","Wang, Hongyang"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32377375","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1038/s41421-020-0168-9","keywords":["immunology","mechanisms of disease"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666262687602966528,"score":237.65543},{"pmid":32294816,"title":"[Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection].","text":["[Bronchoalveolar lavage fluid was used to diagnose two cases of 2019-nCoV infection].","The case reports 2 cases of novel coronavirus pneumonia diagnosed by concurrent bronchoalveolar lavage in our hospital, 1 case had a history of epidemiology, clinical symptoms and high imaging suspicion, but repeated negative throat swabs. One patient was diagnosed 2019-nCoV. Before the patient was discharged, the clinical symptoms disappeared, the chest CT showed significant improvement, and the pharynx swab was twice negative, reaching the discharge standard.We detected the ORF 1ab gene, the N gene and the nucleic acid of the new coronavirus in the broncho-alveolar lavage fluid of 2 patients. The results showed that the positive rate of bronchoalveolar lavage for detection of new coronavirus nucleic acid was high, and bronchoalveolar lavage for suspected or confirmed new coronavirus pneumonia patients with negative detection of nucleic acid in pharynx swabs but still residual lung lesions was helpful for early diagnosis, treatment and prognosis.","Zhonghua Jie He He Hu Xi Za Zhi","Tan, F R","Qiu, Y L","Xu, Z","32294816"],"abstract":["The case reports 2 cases of novel coronavirus pneumonia diagnosed by concurrent bronchoalveolar lavage in our hospital, 1 case had a history of epidemiology, clinical symptoms and high imaging suspicion, but repeated negative throat swabs. One patient was diagnosed 2019-nCoV. Before the patient was discharged, the clinical symptoms disappeared, the chest CT showed significant improvement, and the pharynx swab was twice negative, reaching the discharge standard.We detected the ORF 1ab gene, the N gene and the nucleic acid of the new coronavirus in the broncho-alveolar lavage fluid of 2 patients. The results showed that the positive rate of bronchoalveolar lavage for detection of new coronavirus nucleic acid was high, and bronchoalveolar lavage for suspected or confirmed new coronavirus pneumonia patients with negative detection of nucleic acid in pharynx swabs but still residual lung lesions was helpful for early diagnosis, treatment and prognosis."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Tan, F R","Qiu, Y L","Xu, Z"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32294816","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.3760/cma.j.cn112147-20200224-00167","keywords":["2019-ncov","bronchoalveolar lavage fluid","throat swab","viral nucleic acid testing"],"topics":["Case Report"],"weight":1,"_version_":1666138493220290560,"score":228.44366},{"pmid":32015507,"pmcid":"PMC7095418","title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin.","text":["A pneumonia outbreak associated with a new coronavirus of probable bat origin.","Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats(1-4). Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans(5-7). Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV. In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV.","Nature","Zhou, Peng","Yang, Xing-Lou","Wang, Xian-Guang","Hu, Ben","Zhang, Lei","Zhang, Wei","Si, Hao-Rui","Zhu, Yan","Li, Bei","Huang, Chao-Lin","Chen, Hui-Dong","Chen, Jing","Luo, Yun","Guo, Hua","Jiang, Ren-Di","Liu, Mei-Qin","Chen, Ying","Shen, Xu-Rui","Wang, Xi","Zheng, Xiao-Shuang","Zhao, Kai","Chen, Quan-Jiao","Deng, Fei","Liu, Lin-Lin","Yan, Bing","Zhan, Fa-Xian","Wang, Yan-Yi","Xiao, Geng-Fu","Shi, Zheng-Li","32015507"],"abstract":["Since the outbreak of severe acute respiratory syndrome (SARS) 18 years ago, a large number of SARS-related coronaviruses (SARSr-CoVs) have been discovered in their natural reservoir host, bats(1-4). Previous studies have shown that some bat SARSr-CoVs have the potential to infect humans(5-7). Here we report the identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China. The epidemic, which started on 12 December 2019, had caused 2,794 laboratory-confirmed infections including 80 deaths by 26 January 2020. Full-length genome sequences were obtained from five patients at an early stage of the outbreak. The sequences are almost identical and share 79.6% sequence identity to SARS-CoV. Furthermore, we show that 2019-nCoV is 96% identical at the whole-genome level to a bat coronavirus. Pairwise protein sequence analysis of seven conserved non-structural proteins domains show that this virus belongs to the species of SARSr-CoV. In addition, 2019-nCoV virus isolated from the bronchoalveolar lavage fluid of a critically ill patient could be neutralized by sera from several patients. Notably, we confirmed that 2019-nCoV uses the same cell entry receptor-angiotensin converting enzyme II (ACE2)-as SARS-CoV."],"journal":"Nature","authors":["Zhou, Peng","Yang, Xing-Lou","Wang, Xian-Guang","Hu, Ben","Zhang, Lei","Zhang, Wei","Si, Hao-Rui","Zhu, Yan","Li, Bei","Huang, Chao-Lin","Chen, Hui-Dong","Chen, Jing","Luo, Yun","Guo, Hua","Jiang, Ren-Di","Liu, Mei-Qin","Chen, Ying","Shen, Xu-Rui","Wang, Xi","Zheng, Xiao-Shuang","Zhao, Kai","Chen, Quan-Jiao","Deng, Fei","Liu, Lin-Lin","Yan, Bing","Zhan, Fa-Xian","Wang, Yan-Yi","Xiao, Geng-Fu","Shi, Zheng-Li"],"date":"2020-02-05T11:00:00Z","year":2020,"_id":"32015507","source":"PubMed","week":"20206|Feb 03 - Feb 09","doi":"10.1038/s41586-020-2012-7","link_comment_in":"32070753","locations":["Wuhan","China","sera"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1666138490901889024,"score":182.41547}]}